Yale School of Medicine Receives $10 Million Donation for Type 1 Diabetes Research
The Yale School of Medicine has secured a $10 million gift from the Bukhman Foundation to launch a five-year, multi-investigator research program. The initiative aims to develop precision therapies designed to reverse and eventually cure type 1 diabetes by halting immune attacks on beta cells and restoring insulin production. Led by Dr. Kevan Herold, the program will utilize personalized approaches involving genetic signatures and immunologic profiling. The funding supports a multidisciplinary team of scientists working across immunobiology, computational modeling, and cellular physiology to transform the standard of care for diabetes through disease prevention and reversal.

Topics: immunobiology medical research funding philanthropy type 1 diabetes
Read the full article at PR Newswire
Part of the story Yale School of Medicine Receives $10 Million Donation for Type 1 Diabetes Research (3 articles)